- Home
- SBH vs OCS Comparison
SBH vs OCS Comparison
Compare SBH & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | OCS |
|---|---|---|
| Founded | 1964 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | 3 |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | SBH | OCS |
|---|---|---|
| Price | $13.88 | $29.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $17.25 | ★ $42.00 |
| AVG Volume (30 Days) | ★ 1.2M | 359.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.17 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $3,701,424,000.00 | N/A |
| Revenue This Year | $2.20 | $466.06 |
| Revenue Next Year | $1.82 | $479.73 |
| P/E Ratio | $30.53 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.12 | $16.00 |
| 52 Week High | $17.92 | $30.68 |
Technical Indicators
Market Signals| Indicator | SBH | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 64.28 |
| Support Level | $13.14 | $25.95 |
| Resistance Level | $15.75 | $30.68 |
| Average True Range (ATR) | 0.57 | 1.32 |
| MACD | -0.07 | 0.18 |
| Stochastic Oscillator | 24.40 | 98.55 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.